Neuroendocrine tumors exhibit nested or trabecular and low-grade growth, and express neuroendocrine markers in a widespread manner; they typically express the estrogen receptor, have a low ki67, and are HER2-negative. This evidence concerns the gene ERBB2 and neuroendocrine neoplasm.